Our Services
Medical Information
Helpful Resources
Published on: 7/15/2026
Stage 4 prostate cancer survival varies widely: some patients live 10 years or more after treatment, and select cases have reached 20 years. While the 5-year relative survival rate for metastatic prostate cancer is around 34%, outcomes are steadily improving thanks to advances in hormone therapy, targeted drugs, and immunotherapy. Factors like overall health, cancer subtype, treatment response, and how early advanced disease is detected all influence long-term survival.
If you're worried about prostate cancer symptoms—such as urinary changes, pelvic pain, or unexplained fatigue—don't wait to get clarity. A free, instant, online symptom check can help you understand what your body may be signaling and guide your next steps, whether that's scheduling a screening or talking to a specialist. Early insight can make a meaningful difference in outcomes.
Reviewed for medical accuracy: 07/14/2026
Not seeing your question? No worries.
Submit your own QuestionStage 4 prostate cancer, also known as metastatic prostate cancer, can have varied survival times. While the general prognosis is challenging, some studies have shown that long-term survival is possible.
10-Year Survival: According to research, some patients with metastatic prostate cancer have survived for at least 10 years. This indicates that even in advanced stages, long-term survival can be achieved with appropriate treatment and care.
20-Year Survival: In certain cases, individuals have survived for up to 20 years after receiving initial treatment, such as radical prostatectomy. This highlights the potential for extended survival in some patients, particularly when the cancer is managed effectively from the outset.
These findings suggest that while stage 4 prostate cancer is serious, there is hope for extended survival and even remission in some cases. If you're experiencing concerning symptoms or want to better understand your health situation, you can check your symptoms with Ubie's free AI-powered tool. Treatment approaches and individual factors play a significant role in determining outcomes.
(References)
Tangen CM, Faulkner JR, Crawford ED, Thompson IM, Hirano D, Eisenberger M, & Hussain M. (2003). Ten-year survival in patients with metastatic prostate cancer. Clinical prostate cancer, 15046683.
Ciszewski A, Shackleton D, & Beer TM. (2008). Long-term remission of metastatic small cell carcinoma .... Urology, 18342209.
Mitchell CR, Boorjian SA, Umbreit EC, Rangel LJ, Carlson RE, & Karnes RJ. (2012). 20-Year survival after radical prostatectomy as initial .... BJU international, 22934913.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.